ADIPOQ and metabolic syndrome: A similar profile of increased sICAM and inflammatory biomarkers and decreased adiponectin is observed in patients with dyslipidemia (HDL <1.02 mmol/L, LDL >2.9 mmol/L, or triglyceride >1.2 mmol/L (Table 2).